About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 864 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 864 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 864 trials

TerminatedStudy of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate CancerThis trial will look at the safety and preliminary efficacy of SRF617 in combination with etrumadenant and zimberelimab in patients with metastatic castration-resistant prostate…NCT05177770·Miami, Florida and 8 others Active not recruitingProstate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)Reduction of dose to or 'sparing' of neurovascular structures during stereotactic ablative body radiotherapy (SAbR) for localized prostate cancer will improve retention of sexual…NCT03525262·San Francisco, California and 7 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerThe purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700…NCT01809691·Birmingham, Alabama and 559 others

CompletedTreatment of Prostate Cancer With Adjuvant Bevacizumab Plus ErlotinibThe purpose of this study is to evaluate the safety and effectiveness of bevacizumab plus erlotinib following radical prostatectomy.NCT00203424·Alhambra, California and 15 others

CompletedVaccine Therapy in Treating Patients With Metastatic, Progressive Prostate CancerRATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill tumor cells.NCT00616291·Houston, Texas

Terminated64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)The aim for this study is to determine the safety and efficacy of 67Cu-SAR-BBN in participants with Gastrin Releasing Peptide Receptor (GRPR)-expressing metastatic castrate…NCT05633160·Stanford, California and 5 others

RecruitingOpen-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyThis is a Phase II/III study.NCT06780670·Scottsdale, Arizona and 92 others

TerminatedGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaThis first-in-human (FIH ) study is an open-label, multicenter study that consists of a Phase 1 Dose Escalation/Expansion phase of GB1275 monotherapy or in combination with…NCT04060342·San Francisco, California and 7 others

CompletedA Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate CancerTo determine: * Anti-tumor activity of IPI-504 in 2 groups of subjects with hormone resistant prostate cancer.NCT00564928·San Bernardino, California and 9 others

RecruitingTesting the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine CellsThis phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places…NCT05691465·Duarte, California and 12 others

RecruitingTargeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialThis phase II trial evaluates whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned.NCT06632977·Birmingham, Alabama and 107 others

CompletedAndrogen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerThis phase II trial studies how well androgen deprivation therapy and vorinostat followed by radical prostatectomy works in treating patients with prostate cancer that has not…NCT00589472·Los Angeles, California and 14 others

WithdrawnPhase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate CancerProstate cancer that has returned after local treatment usually responds to hormone blocking treatment, but most patients eventually experience disease progression.NCT01734681·San Antonio, Texas

CompletedAmbulatory Cancer Pain Management: A Feasibility StudyThe primary purpose of this study is to examine the feasibility of collecting pain and other symptom data in outpatient treatment centers across multiple institutions in the Texas…NCT00507351·Houston, Texas and 3 others

Active not recruitingNivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsThis research study is studying a combination of drugs as a possible treatment for rare genitourinary malignancies among four cohorts, bladder or upper tract carcinoma with…NCT03333616·La Jolla, California and 5 others

CompletedStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerThe primary objective in Phase I is to evaluate the safety and tolerability of sacituzumab govitecan-hziy (SG) as a single agent administered in 21-day treatment cycles in…NCT01631552·Aurora, Colorado and 11 others

CompletedABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the BodyA clinical trial examining the safety and effectiveness of ABX-EGF when given to patients with prostate cancer with or without tumor in other parts of the body.NCT00061126·Birmingham, Alabama and 8 others

RecruitingA Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasA phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients with locally advanced or…NCT06999187·Denver, Colorado and 9 others

RecruitingJUR-003 in Adult Patients With Metastatic Prostate CancerJUR-003-ONC-101 is a first-in-human Phase 1a/1b open-label, multicenter study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary anti-tumor activity of…NCT07824349·Grand Rapids, Michigan and 3 others

TerminatedIpilimumab + Androgen Depravation Therapy in Prostate CancerThe goal of this clinical research study is to learn if ipilimumab in combination with either Lupron® (leuprolide), Zoladex® (goserelin), or Firmagon® (degarelix) can affect…NCT01377389·Houston, Texas

PreviousPage 4 of 44Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma